BMI View: We expect Bahrain?s pharmaceutical market values to grow steadily over the coming years.Key drivers will be volume-based, as the growing population increasingly requires more sophisticatedtreatments for lifestyle diseases and as healthcare provision expands and modernises. However, whilesome investment has been made into the local pharmaceutical manufacturing industry, imports willcontinue to supply the bulk of the demand.Headline Expenditure Projections?? Pharmaceuticals: BHD90mn (US$240mn) in 2011 to BHD100mn (US$260mn) in 2012;+6.12% in both local currency and US dollar terms. Forecast unchanged from Q412.?? Healthcare: BHD420mn (US$1.1bn) in 20...
No comments:
Post a Comment